Cargando…

The Role of Renin-Angiotensin-Aldosterone System in the Heart and Lung: Focus on COVID-19

The renin-angiotensin-aldosterone system (RAAS) firstly considered as a cardiovascular circulating hormonal system, it is now accepted as a local tissue system that works synergistically or independently with the circulating one. Evidence states that tissue RAAS locally generates mediators with regu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mascolo, Annamaria, Scavone, Cristina, Rafaniello, Concetta, De Angelis, Antonella, Urbanek, Konrad, di Mauro, Gabriella, Cappetta, Donato, Berrino, Liberato, Rossi, Francesco, Capuano, Annalisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093861/ https://www.ncbi.nlm.nih.gov/pubmed/33959029 http://dx.doi.org/10.3389/fphar.2021.667254

Ejemplares similares

Renin-Angiotensin System and Coronavirus Disease 2019: A Narrative Review
por: Mascolo, Annamaria, et al.
Publicado: (2020)

Quinolones-Induced Musculoskeletal, Neurological, and Psychiatric ADRs: A Pharmacovigilance Study Based on Data From the Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2020)

The Reporting Frequency of Ketoacidosis Events with Dapagliflozin from the European Spontaneous Reporting System: The DAPA-KETO Study
por: di Mauro, Gabriella, et al.
Publicado: (2022)

The New Paradigms in Clinical Research: From Early Access Programs to the Novel Therapeutic Approaches for Unmet Medical Needs
por: Scavone, Cristina, et al.
Publicado: (2019)

Deficit of glucocorticoid‐induced leucine zipper amplifies angiotensin‐induced cardiomyocyte hypertrophy and diastolic dysfunction
por: Cappetta, Donato, et al.
Publicado: (2020)

Pillars and Pitfalls of the New Pharmacovigilance Legislation: Consequences for the Identification of Adverse Drug Reactions Deriving From Abuse, Misuse, Overdose, Occupational Exposure, and Medication Errors
por: Sessa, Maurizio, et al.
Publicado: (2018)

COVID-19 and atrial fibrillation: Intercepting lines
por: Donniacuo, Maria, et al.
Publicado: (2023)

Campania Preventability Assessment Committee (Italy): A Focus on the Preventability of Non-steroidal Anti-inflammatory Drugs' Adverse Drug Reactions
por: Sessa, Maurizio, et al.
Publicado: (2017)

Therapeutic strategies to fight COVID‐19: Which is the status artis?
por: Scavone, Cristina, et al.
Publicado: (2021)

Sodium-Glucose Cotransporter 2 Inhibitors and Heart Failure: A Bedside-to-Bench Journey
por: Cappetta, Donato, et al.
Publicado: (2021)

Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study
por: Scavone, Cristina, et al.
Publicado: (2017)

PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database
por: di Mauro, Gabriella, et al.
Publicado: (2020)

Preventable Cases of Oral Anticoagulant-Induced Bleeding: Data From the Spontaneous Reporting System
por: Mascolo, Annamaria, et al.
Publicado: (2019)

SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment
por: di Mauro, Gabriella, et al.
Publicado: (2020)

Tisagenlecleucel in Children and Young Adults: Reverse Translational Research by Using Real-World Safety Data
por: Rafaniello, Concetta, et al.
Publicado: (2020)

Cardioprotective effects of miR-34a silencing in a rat model of doxorubicin toxicity
por: Piegari, Elena, et al.
Publicado: (2020)

Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: A brief summary
por: Mascolo, Annamaria, et al.
Publicado: (2022)

Current pharmacological treatments for COVID‐19: What's next?
por: Scavone, Cristina, et al.
Publicado: (2020)

COVID-19 Vaccines and Atrial Fibrillation: Analysis of the Post-Marketing Pharmacovigilance European Database
por: Ruggiero, Rosanna, et al.
Publicado: (2023)

Sodium-glucose cotransporter–2 (SGLT2) inhibitors and the reporting of falls and fractures: an european pharmacovigilance analysis
por: Mascolo, Annamaria, et al.
Publicado: (2023)

Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
por: Ruggiero, Rosanna, et al.
Publicado: (2020)

Oxidative Stress and Cellular Response to Doxorubicin: A Common Factor in the Complex Milieu of Anthracycline Cardiotoxicity
por: Cappetta, Donato, et al.
Publicado: (2017)

Glucocorticoid-Induced Leucine Zipper (GILZ) in Cardiovascular Health and Disease
por: Cappetta, Donato, et al.
Publicado: (2021)

Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance
por: Ruggiero, Rosanna, et al.
Publicado: (2022)

Dipeptidyl Peptidase 4 Inhibition Ameliorates Chronic Kidney Disease in a Model of Salt-Dependent Hypertension
por: Cappetta, Donato, et al.
Publicado: (2019)

MicroRNA-34a regulates doxorubicin-induced cardiotoxicity in rat
por: Piegari, Elena, et al.
Publicado: (2016)

Doxorubicin cardiotoxicity and target cells: a broader perspective
por: De Angelis, Antonella, et al.
Publicado: (2016)

Ranolazine Counteracts Strength Impairment and Oxidative Stress in Aged Sarcopenic Mice
por: Torcinaro, Alessio, et al.
Publicado: (2022)

Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance
por: Mascolo, Annamaria, et al.
Publicado: (2021)

Contrast media-induced nephropathy: how has Italy contributed in the past 30 years? A systematic review
por: Sessa, Maurizio, et al.
Publicado: (2017)

Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System
por: Scavone, Cristina, et al.
Publicado: (2019)

Emergence and evolution of the renin–angiotensin–aldosterone system
por: Fournier, David, et al.
Publicado: (2012)

Beyond the Circulating Renin–Angiotensin Aldosterone System
por: De Mello, Walmor C.
Publicado: (2014)

The renin‐angiotensin‐aldosterone system and its suppression
por: Ames, Marisa K., et al.
Publicado: (2019)

The renin angiotensin aldosterone system and COVID-19
por: Alsufyani, Hadeel A., et al.
Publicado: (2020)

Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
por: Benenson, Irina, et al.
Publicado: (2020)

Editorial: New Trends in the Renin-Angiotensin-Aldosterone System in Cardiovascular Disease
por: Szczepanska-Sadowska, Ewa, et al.
Publicado: (2021)

Role of the Renin-Angiotensin System and Aldosterone on Cardiometabolic Syndrome
por: Stiefel, P., et al.
Publicado: (2011)

The Renin-Angiotensin-Aldosterone System in Vascular Inflammation and Remodeling
por: Pacurari, Maricica, et al.
Publicado: (2014)

Independent regulation of renin–angiotensin–aldosterone system in the kidney
por: Nishiyama, Akira, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1qk8t9vvjuhsssjvo1blrauf6b